Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
During the current COVID-19 Pandemic, all communities are relying heavily on medical personnel and first-responders to maintain high levels of psychological and occupational functioning. However, during times of persistent high levels of stress, many individuals experience depletion in psychological resources, suffering intense distress that can make daily occupational and interpersonal functioning difficult. In order to assist with this immense challenge, this research team has developed a brief daily intervention based on decades of stress and trauma research that may help to support psychological health in individuals on the frontlines who are most essential to society. Considerable evidence supports the role of attention to and conceptualization of emotional experience in psychological resilience. This project tests a highly innovative combination of interventions targeting these processes in a brief, daily activity. The primary project aim is to investigate the Daily Coping Toolkit for medical personnel and first responders to determine efficacy over time, to test relative dosing, and to explicate the underlying therapeutic processes. The toolkit consists of 3 activities, administered one time each day, taking minutes to complete and will be administered to n=1000 personnel. Data analysis will test the impact of the toolkit on momentary affective processes and on symptoms and wellbeing over 9 months. The impact of this research will be evidence to support the further use of this novel tool to assist essential front-line personnel during this ongoing crisis helping to mitigate the psychological toll and also support occupational functioning now and in the future.
Description: Patient Health Questionnaire 4 items, Kroenke, Spitzer, Williams & Lowe, 2009
Measure: Patient Health Questionnaire - 4 Time: 1 weekDescription: Patient Health Questionnaire 4 items, Kroenke, Spitzer, Williams & Lowe, 2009
Measure: Patient Health Questionnaire - 4 Time: 9 weeksDescription: Patient Health Questionnaire 4 items, Kroenke, Spitzer, Williams & Lowe, 2009
Measure: Patient Health Questionnaire - 4 Time: 26 weeksDescription: Patient Health Questionnaire 4 items, Kroenke, Spitzer, Williams & Lowe, 2009
Measure: Patient Health Questionnaire - 4 Time: 40 weeksDescription: 2 items from the WHO-5: Beck 2004
Measure: World Health Organization Well Being Questionnaire Time: 1 weekDescription: 2 items from the WHO-5: Beck 2004
Measure: World Health Organization Well Being Questionnaire Time: 9 weeksDescription: 2 items from the WHO-5: Beck 2004
Measure: World Health Organization Well Being Questionnaire Time: 26 weeksDescription: 2 items from the WHO-5: Beck 2004
Measure: World Health Organization Well Being Questionnaire Time: 40 weeksDescription: Reported negative and positive emotions: Coifman et al, 2016
Measure: Affective Experience Time: 1 weekDescription: Adapted from Hunsley, 1992, assessed subjective experience with intervention
Measure: Treatment Acceptability Questionnaire Time: 1 weekAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports